These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 37426619)

  • 41. Identification of saquinavir as a potent inhibitor of dimeric SARS-CoV2 main protease through MM/GBSA.
    Bello M; Martínez-Muñoz A; Balbuena-Rebolledo I
    J Mol Model; 2020 Nov; 26(12):340. PubMed ID: 33184722
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sitagliptin: a potential drug for the treatment of COVID-19?
    Bardaweel SK; Hajjo R; Sabbah DA
    Acta Pharm; 2021 Jun; 71(2):175-184. PubMed ID: 33151168
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The emergence of COVID-19 as a global pandemic: Understanding the epidemiology, immune response and potential therapeutic targets of SARS-CoV-2.
    Muralidar S; Ambi SV; Sekaran S; Krishnan UM
    Biochimie; 2020 Dec; 179():85-100. PubMed ID: 32971147
    [TBL] [Abstract][Full Text] [Related]  

  • 44.
    Gurung AB; Ali MA; Lee J; Abul Farah M; Al-Anazi KM
    Saudi J Biol Sci; 2020 Oct; 27(10):2674-2682. PubMed ID: 32837219
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In silico identification of widely used and well-tolerated drugs as potential SARS-CoV-2 3C-like protease and viral RNA-dependent RNA polymerase inhibitors for direct use in clinical trials.
    Gul S; Ozcan O; Asar S; Okyar A; Barıs I; Kavakli IH
    J Biomol Struct Dyn; 2021 Oct; 39(17):6772-6791. PubMed ID: 32752938
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Global Phosphorylation Landscape of SARS-CoV-2 Infection.
    Bouhaddou M; Memon D; Meyer B; White KM; Rezelj VV; Correa Marrero M; Polacco BJ; Melnyk JE; Ulferts S; Kaake RM; Batra J; Richards AL; Stevenson E; Gordon DE; Rojc A; Obernier K; Fabius JM; Soucheray M; Miorin L; Moreno E; Koh C; Tran QD; Hardy A; Robinot R; Vallet T; Nilsson-Payant BE; Hernandez-Armenta C; Dunham A; Weigang S; Knerr J; Modak M; Quintero D; Zhou Y; Dugourd A; Valdeolivas A; Patil T; Li Q; Hüttenhain R; Cakir M; Muralidharan M; Kim M; Jang G; Tutuncuoglu B; Hiatt J; Guo JZ; Xu J; Bouhaddou S; Mathy CJP; Gaulton A; Manners EJ; Félix E; Shi Y; Goff M; Lim JK; McBride T; O'Neal MC; Cai Y; Chang JCJ; Broadhurst DJ; Klippsten S; De Wit E; Leach AR; Kortemme T; Shoichet B; Ott M; Saez-Rodriguez J; tenOever BR; Mullins RD; Fischer ER; Kochs G; Grosse R; García-Sastre A; Vignuzzi M; Johnson JR; Shokat KM; Swaney DL; Beltrao P; Krogan NJ
    Cell; 2020 Aug; 182(3):685-712.e19. PubMed ID: 32645325
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV.
    Ou X; Liu Y; Lei X; Li P; Mi D; Ren L; Guo L; Guo R; Chen T; Hu J; Xiang Z; Mu Z; Chen X; Chen J; Hu K; Jin Q; Wang J; Qian Z
    Nat Commun; 2020 Mar; 11(1):1620. PubMed ID: 32221306
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CD13/Aminopeptidase N Is a Potential Therapeutic Target for Inflammatory Disorders.
    Lu C; Amin MA; Fox DA
    J Immunol; 2020 Jan; 204(1):3-11. PubMed ID: 31848300
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dihydroergotamine (DHE) - Then and Now: A Narrative Review.
    Silberstein SD; Shrewsbury SB; Hoekman J
    Headache; 2020 Jan; 60(1):40-57. PubMed ID: 31737909
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
    Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
    Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Virtual high-throughput screening: Potential inhibitors targeting aminopeptidase N (CD13) and PIKfyve for SARS-CoV-2.
    Ruan Z; Tang J; Zeng M; Fan P
    Open Life Sci; 2023; 18(1):20220637. PubMed ID: 37426619
    [TBL] [Abstract][Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.